• Thu, August 8, 2024

David Amsellem Maintained (AMPH) at Buy with Decreased Target to $66 on, Aug 8th, 2024

David Amsellem of Piper Sandler, Maintained "Amphastar Pharmaceuticals, Inc." (AMPH) at Buy with Decreased Target from $71 to $66 on, Aug 8th, 2024.

David, nor any peers, have made any analyst calls on AMPH in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30